August 31 -- Harbin Pharmaceutical Group (600664.SH) reported a 15.13 percent increase in net profit to 650 million yuan in the first half of 2011, reports p5w.net, citing a company filing. Sales revenue in the first half increase 16.98 percent to 7.67 billion yuan, with earnings per share (EPS) of 0.4 yuan, up 14.29 percent. The percentage changes are year-on-year.

The company attributed the strong sales performance to an improved product structure and innovative marketing methods.